Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients

[1]  G. Chertow,et al.  Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial. , 2019, Journal of the American Society of Nephrology : JASN.

[2]  J. Caldwell,et al.  Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability , 2018, Science Translational Medicine.

[3]  H. Miyata,et al.  The importance of nutritional intervention by dietitians for hyperphosphatemia in maintained hemodialysis patients , 2017, Renal Replacement Therapy.

[4]  Ananda Sen,et al.  Phosphate binder pill burden, patient‐reported non‐adherence, and mineral bone disorder markers: Findings from the DOPPS , 2016, Hemodialysis international. International Symposium on Home Hemodialysis.

[5]  W. S. St. Peter,et al.  Management of Polypharmacy in Dialysis Patients , 2015, Seminars in dialysis.

[6]  M. Fukagawa,et al.  A Japanese approach for CKD-MBD , 2013, Kidney international supplements.

[7]  K. Iseki,et al.  Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[8]  A. Ortiz,et al.  Phosphorus and Nutrition in Chronic Kidney Disease , 2012, International journal of nephrology.

[9]  K. Martin,et al.  Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[10]  Yi-Wen Chiu,et al.  Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[11]  A. Hutchison.  Oral phosphate binders. , 2009, Kidney international.

[12]  Supplemental Tables,et al.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2009, Kidney international. Supplement.

[13]  National Kidney Foundation K-DOQI: Clinical practice guidelines for bone metabolism and disease in chronic kidney disease , 2007 .